Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.
Papp V, Magyari M, Aktas O, Berger T, Broadley SA, Cabre P, Jacob A, Kira JI, Leite MI, Marignier R, Miyamoto K, Palace J, Saiz A, Sepulveda M, Sveinsson O, Illes Z. Papp V, et al. Neurology. 2021 Jan 12;96(2):59-77. doi: 10.1212/WNL.0000000000011153. Epub 2020 Dec 11. Neurology. 2021. PMID: 33310876 Free PMC article.
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.
Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T. Papp V, et al. Neurology. 2018 Dec 11;91(24):e2265-e2275. doi: 10.1212/WNL.0000000000006645. Epub 2018 Nov 9. Neurology. 2018. PMID: 30413632 Free PMC article.
A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.
Papp V, Iljicsov A, Rajda C, Magyari M, Koch-Henriksen N, Petersen T, Jakab G, Deme I, Nagy F, Imre P, Lohner Z, Kovács K, Birkás AJ, Köves Á, Rum G, Nagy Z, Kerényi L, Vécsei L, Bencsik K, Jobbágy Z, Diószeghy P, Horváth L, Galántai G, Kasza J, Molnár G, Simó M, Sátori M, Rózsa C, Ács P, Berki T, Lovas G, Komoly S, Illes Z. Papp V, et al. Eur J Neurol. 2020 Feb;27(2):308-317. doi: 10.1111/ene.14079. Epub 2019 Sep 30. Eur J Neurol. 2020. PMID: 31465603
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis.
Chalmer TA, Buron M, Illes Z, Papp V, Theodorsdottir A, Schäfer J, Hansen V, Asgari N, Skejø PB, Jensen HB, Sørensen PS, Magyari M. Chalmer TA, et al. Among authors: papp v. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):67-74. doi: 10.1136/jnnp-2019-321523. Epub 2019 Nov 14. J Neurol Neurosurg Psychiatry. 2020. PMID: 31727727
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Buron MD, Chalmer TA, Sellebjerg F, Barzinji I, Danny B, Christensen JR, Christensen MK, Hansen V, Illes Z, Jensen HB, Kant M, Papp V, Petersen T, Prakash S, Rasmussen PV, Schäfer J, Theódórsdóttir Á, Weglewski A, Sorensen PS, Magyari M. Buron MD, et al. Among authors: papp v. Neurology. 2020 Aug 25;95(8):e1041-e1051. doi: 10.1212/WNL.0000000000010135. Epub 2020 Jul 7. Neurology. 2020. PMID: 32636328
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
Papp V, Buron MD, Siersma V, Rasmussen PV, Illes Z, Kant M, Hilt C, Mezei Z, Roshanisefat H, Sejbæk T, Weglewski A, van Wingerden J, Geertsen SS, Bramow S, Sellebjerg F, Magyari M. Papp V, et al. PLoS One. 2021 May 18;16(5):e0250820. doi: 10.1371/journal.pone.0250820. eCollection 2021. PLoS One. 2021. PMID: 34003862 Free PMC article.
74 results